Concepedia
1
Publications
145
Citations
H-Index
2020
Active since
Affiliations
University of California, San Francisco(Current)
Emily Bergsland is an author at University of California, San Francisco.
Publications per year
2020–2020
Pembrolizumab for the treatment of programmed death–ligand 1‒positive advanced carcinoid or pancreatic neuroendocrine tumors: Results from the KEYNOTE‐028 study
Janice M. Mehnert, Emily Bergsland, Bert H. O’Neil et al. · Cancer · 2020 · 145 citations · Full text
Rows per page
1–1 of 1